OrSense’s non-invasive hemoglobin (Hb) measurement system, NBM 200MP, was found to monitor blood loss continuously and detect hemorrhages within minutes.
The portable non-invasive device operates via a ring-shaped sensor fitted to the subject’s finger which applies pressure, temporarily occluding local blood flow.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The trial was conducted on 12 healthy volunteers in the VA Medical Center and hemorrhage conditions were analysed by drawing two units of blood from each subject.
It is found that the sensitivity of the NBM 200MP was 96% compared to an invasive, ‘golden standard’ measurement, and the non-invasive monitor detected hemorrhage in less than four minutes.
OrSense CEO Lior Maayan said the study showed the continuous Hb monitor offers, for the first time, the ability to detect hemorrhages within minutes, with minimal effort and cost.
”The NBM 200MP can be instrumental in saving lives and reducing hospitalisation complications and costs," Maayan said.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
